The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics will begin this Monday, October 22, 2007 at the Moscone Convention Center in San Francisco, California. Scheduled to be presented at the conference, which runs through October 26th, will be interim results of the combination Reolysin and radiation trial.
View the program here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment